FEV1 0 4 0 4 B-clinical_variable
% 4 5 4 5 I-clinical_variable
> 6 7 6 7 O
35 7 9 7 9 B-lower_bound
% 9 10 9 10 I-lower_bound
, 10 11 10 11 O
O2 12 14 12 14 B-clinical_variable
saturation 15 25 15 25 I-clinical_variable
> 26 27 26 27 O
90 27 29 27 29 B-lower_bound
% 29 30 29 30 I-lower_bound
on 31 33 31 33 O
room 34 38 34 38 O
air 39 42 39 42 O
, 42 43 42 43 O
clinically 44 54 44 54 O
stable 55 61 55 61 O
with 62 66 62 66 O
no 67 69 67 69 O
significant 70 81 70 81 O
changes 82 89 82 89 O
in 90 92 90 92 O
health 93 99 93 99 O
status 100 106 100 106 O
for 107 110 107 110 O
14 111 113 111 113 B-upper_bound
days 114 118 114 118 I-upper_bound
prior 119 124 119 124 I-upper_bound
to 125 127 125 127 O
Day 128 131 128 131 O
1 132 133 132 133 O

Pregnant 0 8 134 142 B-pregnancy

Use 0 3 143 146 O
of 4 6 147 149 O
any 7 10 150 153 O
investigational 11 26 154 169 O
drug 27 31 170 174 O
and/or 32 38 175 181 O
participated 39 51 182 194 O
in 52 54 195 197 O
any 55 58 198 201 O
interventional 59 73 202 216 O
clinical 74 82 217 225 O
trial 83 88 226 231 O
within 89 95 232 238 O
28 96 98 239 241 B-upper_bound
days 99 103 242 246 I-upper_bound
prior 104 109 247 252 I-upper_bound
to 110 112 253 255 O
screening 113 122 256 265 O

aged 0 4 266 270 B-age
16 5 7 271 273 B-lower_bound
- 7 8 273 274 O
80 8 10 274 276 B-upper_bound

clinically 0 10 277 287 O
stable 11 17 288 294 O
with 18 22 295 299 O
no 23 25 300 302 O
significant 26 37 303 314 O
changes 38 45 315 322 O
in 46 48 323 325 O
health 49 55 326 332 O
status 56 62 333 339 O
for 63 66 340 343 O
14 67 69 344 346 B-upper_bound
days 70 74 347 351 I-upper_bound
prior 75 80 352 357 I-upper_bound
to 81 83 358 360 O
Day 84 87 361 364 O
1 88 89 365 366 O

